FDA approves venetoclax for CLL/SLL with or without del 17pJune 10, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
Emicizumab granted priority review for hemophilia A without inhibitorsJune 7, 2018ThrombosisPharmacyBleeding Disorders
FDA approves first biosimilar pegfilgrastimJune 5, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
Over 1100 new meds, vaccines being developed to treat cancerJune 4, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
FDA grants priority review to gilteritinib for R/R AMLMay 30, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
Cost of imatinib still high despite generic options, team saysMay 8, 2018Leukemia, Myelodysplasia, TransplantationPharmacyCML
CHMP backs approval of dasatinib for kidsApril 30, 2018Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyCML
CHMP recommends approval for generic carmustineApril 28, 2018Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
